Vascular Surgeons diagnose and treat a range of conditions affecting the blood vessels, including arteries, veins, and capillaries. These professionals manage vascular issues such as peripheral artery disease (PAD), aneurysms, varicose veins, and carotid artery disease. Common procedures performed by vascular surgeons include angioplasty, stenting, bypass surgery, and endovascular aneurysm repair (EVAR). The goal of treatment is to improve circulation, alleviate pain, and prevent severe outcomes, such as stroke, amputation, or organ damage, that can result from untreated vascular conditions. By carefully tailoring treatments to each patient’s unique needs, vascular surgeons help ensure effective and lasting results.
Surgical interventions, vascular surgeons also play a critical role in managing risk factors that contribute to vascular diseases. They work closely with patients to control conditions such as high cholesterol, hypertension, diabetes, and smoking, which can accelerate the progression of vascular issues. Through personalized advice on lifestyle modifications, medication management, and routine monitoring, they help slow the progression of vascular diseases and prevent further complications. This holistic approach to treatment and prevention enables patients to not only recover but also maintain long-term vascular health. By addressing both immediate health concerns and long-term well-being, vascular surgeons significantly enhance their patients’ quality of life and reduce the risk of future cardiovascular events.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India